InsiderTradesSIGMA

InsidersTradesSigma

← Executives ★ Sign in to follow

PT

Phil Thomson

CEO

Cumul. flow

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

0

T+90 hit rate

0%

T+90 mean return

-15.1%

Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Browse the full record of transactions filed by Phil Thomson. Director active across 1 company, notably GSK plc. In total, 33 filings have been published. History available since 9 August 2023. The latest transaction was filed on 13 February 2026 (Sale). Regulator: RNS (LSE). The full history is accessible without signup.

Declarations33 total

●

President, Global AffairsExecutives13 Feb 2026GSK plc

79,007 shares0N/ARNS:9e068048-67e6-4a53-8636-ebe7180e6da4-20

●

President, Global AffairsExecutives13 Feb 2026GSK plc

£802,10224RNS ↗

37,134 shares@ £21.600215.2% of flowLondon Stock Exchange (XLON)RNS:9e068048-67e6-4a53-8636-ebe7180e6da4-21

●

President, Global AffairsExecutives12 Feb 2026GSK plc

£304,59123RNS ↗

14,167 shares@ £21.505.8% of flowN/ARNS:6207777f-2477-470b-868f-21f92714189a-7

●

President, Global AffairsExecutives12 Feb 2026GSK plc

66,221 shares@ £21.5027.0% of flowN/ARNS:586c5c74-54b9-425a-a37c-ba21836ecce7-11

●

President, Global AffairsExecutives9 Feb 2026GSK plc

18,321 shares0N/ARNS:527591f3-f598-44b4-87bb-f5cfd91a36cb-12

●

President, Global AffairsExecutives9 Feb 2026GSK plc

£190,02722RNS ↗

8,633 shares@ £22.01173.6% of flowLondon Stock Exchange (XLON)RNS:527591f3-f598-44b4-87bb-f5cfd91a36cb-13

●

President, Global AffairsExecutives17 Feb 2025GSK plc

£270,29723RNS ↗

18,836 shares@ £14.3511.0% of flowN/ARNS:5546650-9

●

President, Global AffairsExecutives18 Feb 2025GSK plc

70,869 shares0N/ARNS:5546637-15

●

President, Global AffairsExecutives18 Feb 2025GSK plc

£474,75724RNS ↗

33,309 shares@ £14.253119.5% of flowLondon Stock Exchange (XLON)RNS:5546637-16

●

President, Global AffairsExecutives17 Feb 2025GSK plc

11,220 shares0N/ARNS:5546603-18

●

President, Global AffairsExecutives17 Feb 2025GSK plc

£75,03822RNS ↗

5,287 shares@ £14.19293.1% of flowLondon Stock Exchange (XLON)RNS:5546603-19

●

President, Global AffairsExecutives16 Jul 2024GSK plc

0London Stock Exchange (XLON)RNS:5272433-8

Ideal exit: 12 Apr 2025 (T+270)

●

President, Global AffairsExecutives16 Apr 2024GSK plc

0London Stock Exchange (XLON)RNS:5149697-8

Ideal exit: 11 Jan 2025 (T+270)

●

President, Global AffairsExecutives12 Feb 2024GSK plc

3,081 sharesLondon Stock Exchange (XLON)RNS:5069455-17

●

President, Global AffairsExecutives12 Feb 2024GSK plc

6,532 sharesN/ARNS:5069455-16

●

President, Global AffairsExecutives9 Feb 2024GSK plc

73,728 shares0N/ARNS:5066290-17

●

President, Global AffairsExecutives9 Feb 2024GSK plc

£575,43025RNS ↗

34,653 shares@ £16.605534.6% of flowLondon Stock Exchange (XLON)RNS:5066290-18

●

President, Global AffairsExecutives9 Feb 2024GSK plc

£575,43025RNS ↗

34,653 shares@ £16.605534.6% of flowLondon Stock Exchange (XLON)RNS:5066262-18

●

President, Global AffairsExecutives9 Feb 2024GSK plc

73,728 shares0N/ARNS:5066262-17

●

President, Global AffairsExecutives9 Feb 2024GSK plc

£23322RNS ↗

14 shares@ £16.61930.0% of flowLondon Stock Exchange (XLON)RNS:5064746-6

Ideal exit: 5 Nov 2024 (T+270)

●

President, Global AffairsExecutives8 Feb 2024GSK plc

£501,62925RNS ↗

29,991 shares@ £16.72630.1% of flowN/ARNS:5064721-9

●

President, Global AffairsExecutives16 Jan 2024GSK plc

0London Stock Exchange (XLON)RNS:5039401-8

Ideal exit: 12 Oct 2024 (T+270)

●

President, Global AffairsExecutives15 Jan 2024GSK plc

£4,73122RNS ↗

304 shares@ £15.5640.3% of flowLondon Stock Exchange (XLON)RNS:5036421-9

●

President, Global AffairsExecutives11 Jan 2024GSK plc

£59522RNS ↗

38 shares@ £15.65180.0% of flowLondon Stock Exchange (XLON)RNS:5034561-16

Ideal exit: 7 Oct 2024 (T+270)

●

President, Global AffairsExecutives10 Jan 2024GSK plc

£25122RNS ↗

16 shares@ £15.7050.0% of flowLondon Stock Exchange (XLON)RNS:5034561-6

Ideal exit: 6 Oct 2024 (T+270)

25 of 33 declarations

About Phil Thomson

Phil Thomson is a declarant who has made 33 filings in total. In his most recent filings, he made a purchase valued at 3,380 EUR and sales totaling 3,147,982 EUR. The sampled filings range from August 10, 2023, to February 17, 2026. Among his filings, the largest is a transaction of 1,633,128.45 EUR published on February 16, 2026, for GSK plc.